©2019 by NIRCOM. 

Meet Our Team

Dr. Asher Holzer

Chairman

Dr. Asher Holzer gained a PhD in Applied Physics from the Hebrew University in Jerusalem, Israel, where he also received a M.Sc. in Material Science and B.Sc. in Mathematics, Physics and Computer Science.

 

He is a serial entrepreneur with over 30 years of senior leadership experience in the Medical Device industry, transitioning emerging technologies from research to clinical care, raising venture capital funds and taking companies public. 

 

Dr. Asher Holzer is the founder of several MedTech companies and served as a Director and Chairman of the board with both start-ups and led their IPO to be publicly traded companies in the NASDAQ and other national exchanges including  InspireMD (NYSE MKT: NSPR)  UroGen Pharma ( NASDAQ: URGN).  BioSig (USA), and others.

 

Dr. Asher Holzer is also highly involved in the Israeli Medical Cannabis market serving as Chairman of the board of HiPharma, a leading Israeli licensing producer and as a Director of Medivie, a publicly traded holding company in the Medical Cannabis space.

Dr. Asher Holzer holds several granted and pending patents and He serves as a director in several start-up companies and as a consultant to several medical device companies and investment funds.